Search Results - "Aldouri, M"
-
1
-
2
-
3
-
4
-
5
-
6
High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation
Published in Acta haematologica (1990)“…Cardiac scintigraphy has been performed in 60 beta-thalassaemia major patients aged 8-35 years who received regular blood transfusions and subcutaneous…”
Get more information
Journal Article -
7
1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload
Published in The Lancet (British edition) (06-06-1987)“…Subcutaneous desferrioxamine, though effective in preventing or reducing iron overload in transfusion-dependent refractory anaemia, is expensive and…”
Get more information
Journal Article -
8
Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine
Published in Journal of clinical pathology (01-11-1987)“…Liver biopsies were performed on 51 regularly transfused patients with beta thalassaemia, age range 5-36 (mean 18.6) years, who had received regular…”
Get full text
Journal Article -
9
The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients
Published in Pathophysiology of haemostasis and thrombosis (01-01-2002)“…Recombinant factor VIIa (rFVIIa, NovoSeven) is effective and appears safe in the management of bleeding episodes and provision of surgical cover in haemophilia…”
Get more information
Journal Article -
10
Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease
Published in Archives of disease in childhood (01-04-1989)“…Thirty two patients with beta thalassaemia and sickle cell disease who were having regular blood transfusions were selected to test the efficacy and…”
Get full text
Journal Article -
11
Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA
Published in Archives of disease in childhood (01-01-1989)“…Auditory neurotoxicity occurred in 13 (26%) of 50 evaluable patients receiving long term desferrioxamine chelation. In five of these patients, all of whom were…”
Get full text
Journal Article -
12
Cardiac transplantation for doxorubicin-induced cardiomyopathy in acute myeloid leukaemia
Published in British journal of haematology (01-04-1990)Get more information
Journal Article -
13
Deletion of chromosome arm 15q and hitherto unreported duplication of del(15q) in myeloid disorders
Published in Cancer genetics and cytogenetics (01-06-2004)“…Deletion of the long arm of chromosome 15 has been described as a recurrent chromosomal abnormality in myeloid malignancies. We present here some additional…”
Get full text
Journal Article -
14
Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes
Published in Cancer genetics and cytogenetics (15-01-2005)“…Interstitial deletion of the long arm of chromosome 20, as the sole abnormality, is commonly observed in myeloid malignancies, including myeloproliferative…”
Get full text
Journal Article -
15
Racial differences in the energy cost of standardised activities
Published in Annals of nutrition and metabolism (1985)“…The assumption is currently made by international organisations that individuals of the same size living in the same environment and having the same mode of…”
Get more information
Journal Article -
16
Cardiac complications in homozygous beta-thalassemia
Published in Progress in clinical and biological research (1989)Get more information
Journal Article -
17
A221 Outcomes in Relapsed Multiple Myeloma in the United Kingdom
Published in Clinical lymphoma & myeloma (01-02-2009)Get full text
Journal Article -
18
Severe acquired haemophilia A treated with recombinant factor VIIa
Published in British journal of haematology (01-09-1997)“…Acquired haemophilia can be associated with various conditions including pregnancy, autoimmune diseases and lymphoproliferative disorders, though often no…”
Get full text
Journal Article -
19
Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one
Published in British Medical Journal (Clinical research ed.) (12-12-1987)“…The main iron chelator used for transfusional iron overload is desferrioxamine, which is expensive, has toxic side effects, and has to be given subcutaneously…”
Get full text
Journal Article -
20